A Clinical Study of Tobradex AF

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00473070

Enrollment

900

Registered

2007-05-14

Start date

2006-11-30

Completion date

Unknown

Last updated

2008-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Interventions

DRUGTobradex AF

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients requiring cataract surgery

Exclusion criteria

* Age related

Design outcomes

Primary

Measure	Time frame
Concentration of dexamethasone in aqueous humor following a single topical ocular administration	Periodic

Secondary

Measure	Time frame
Changes in external and internal ocular structures, intraocular pressure, vision and other side effects	Periodic

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026